Prestige Consumer Healthcare Inc.
PBH · XNYSCIK 1295947fmd_1W5M0PDAYKS2ZQ70BZ47SBPCVRManufacturing · Pharmaceutical PreparationsTemplate: Standard
Coverage: Apr 01, 2009 to Sep 30, 2026, 67 periods
| Line item | FY2017 | FY2018 | FY2019 | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 | FY2026 |
|---|---|---|---|---|---|---|---|---|---|---|
| Total revenues | 882 | 1,041 | 976 | 963 | 943 | 1,087 | 1,128 | 1,125 | 1,138 | 1,089 |
| Cost of revenue | 382 | 465 | 420 | 411 | 396 | 466 | 502 | 501 | 503 | 493 |
| Net interest income | – | – | – | – | – | (64) | (69) | (67) | (48) | (42) |
| Gross profit | 500 | 577 | 556 | 552 | 547 | 621 | 625 | 624 | 634 | 596 |
| Provision for credit losses | – | – | – | – | – | – | – | 0 | 0 | 10 |
| Net interest income after provision | – | – | – | – | – | – | – | (67) | (48) | (53) |
| Total operating expenses | 295 | 361 | 488 | 261 | 250 | 291 | 648 | 282 | 298 | 286 |
| Operating income | 206 | 215 | 68 | 291 | 297 | 330 | (22) | 342 | 337 | 309 |
| Interest expense | 94 | 106 | 105 | 96 | 82 | 64 | 4 | 5 | 2 | – |
| Interest and investment income | 0 | 0 | 0 | 0 | – | – | – | – | – | – |
| Other non-operating income (expense) | (0) | 0 | (0) | (2) | 1 | (1) | (2) | 1 | (5) | (10) |
| Income before taxes | 111 | 107 | (38) | 191 | 204 | 262 | (94) | 276 | 284 | 257 |
| Income tax expense | 41 | (232) | (2) | 49 | 39 | 57 | (12) | 67 | 70 | 67 |
| Net income from continuing operations | 69 | 340 | (36) | 142 | 165 | 205 | (82) | 209 | 215 | 190 |
| Net income | 69 | 340 | (36) | 142 | 165 | 205 | (82) | 209 | 215 | 190 |